These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31737208)

  • 21. Silencing of long non-coding RNA DLX6-AS1 weakens neuroblastoma progression by the miR-513c-5p/PLK4 axis.
    Jia P; Wei E; Liu H; Wu T; Wang H
    IUBMB Life; 2020 Dec; 72(12):2627-2636. PubMed ID: 33031637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long Noncoding RNA
    Xie F; Xie G; Sun Q
    Cancer Biother Radiopharm; 2020 Mar; 35(2):129-136. PubMed ID: 32077747
    [No Abstract]   [Full Text] [Related]  

  • 23. Long noncoding RNA DLX6-AS1 promotes neuroblastoma progression by regulating miR-107/BDNF pathway.
    Zhang HY; Xing MQ; Guo J; Zhao JC; Chen X; Jiang Z; Zhang H; Dong Q
    Cancer Cell Int; 2019; 19():313. PubMed ID: 31787850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DLX6 Antisense RNA 1 Modulates Glucose Metabolism and Cell Growth in Gastric Cancer by Targeting microRNA-4290.
    Qian Y; Song W; Wu X; Hou G; Wang H; Hang X; Xia T
    Dig Dis Sci; 2021 Feb; 66(2):460-473. PubMed ID: 32239379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axis.
    Wu C; Lin W; Fu F
    Transl Cancer Res; 2021 Aug; 10(8):3772-3787. PubMed ID: 35116677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA DLX6-AS1 functions as a competing endogenous RNA for miR-577 to promote malignant development of colorectal cancer.
    Zhou FR; Pan ZP; Shen F; Huang LQ; Cui JH; Cai K; Guo XL
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3742-3748. PubMed ID: 31115000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA DLX6-AS1 increases the expression of HIF-1α and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR-199a-5p.
    Yang B; Jia L; Ren H; Jin C; Ren Q; Zhang H; Hu D; Zhang H; Hu L; Xie T
    Mol Genet Genomic Med; 2020 Jan; 8(1):e1017. PubMed ID: 31782911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The regulatory network of lncRNA DLX6-AS1/miR-149-5p/ERP44 is possibly related to the progression of preeclampsia.
    Liu R; Wang X; Yan Q
    Placenta; 2020 Apr; 93():34-42. PubMed ID: 32250737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.
    Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J
    Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promising long noncoding RNA DLX6-AS1 in malignant tumors.
    Xue C; Lv L; Jiang J; Li L
    Am J Transl Res; 2020; 12(12):7682-7692. PubMed ID: 33437353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA DLX6-AS1 promotes tumor proliferation and metastasis in osteosarcoma through modulating miR-641/HOXA9 signaling pathway.
    Zhang N; Meng X; Mei L; Zhao C; Chen W
    J Cell Biochem; 2019 Jul; 120(7):11478-11489. PubMed ID: 30838699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancer.
    An Y; Chen XM; Yang Y; Mo F; Jiang Y; Sun DL; Cai HH
    Cancer Cell Int; 2018; 18():143. PubMed ID: 30250401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA DLX6-AS1 is upregulated in preeclampsia and modulates migration and invasion of trophoblasts through the miR-376c/GADD45A axis.
    Tan Y; Xiao D; Xu Y; Wang C
    Exp Cell Res; 2018 Sep; 370(2):718-724. PubMed ID: 30055134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long Noncoding RNA DLX6-AS1 Regulates the Growth and Aggressiveness of Colorectal Cancer Cells Via Mediating the miR-26a/EZH2 Axis.
    Kong WQ; Liang JJ; Du J; Ye ZX; Gao P; Liang YL
    Cancer Biother Radiopharm; 2021 Nov; 36(9):753-764. PubMed ID: 32379493
    [No Abstract]   [Full Text] [Related]  

  • 36. Upregulation of long noncoding RNA DLX6-AS1 promotes cell growth and metastasis in esophageal squamous cell carcinoma via targeting miR-577.
    Wu SB; Wang HQ
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1195-1201. PubMed ID: 32096208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
    Liang Y; Zhang CD; Zhang C; Dai DQ
    Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DLX6-AS1: An Indispensable Cancer-related Long Non-coding RNA.
    Hu C; Liu K; Wang B; Xu W; Lin Y; Yuan C
    Curr Pharm Des; 2021; 27(9):1211-1218. PubMed ID: 33121401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells.
    Wu DM; Zheng ZH; Zhang YB; Fan SH; Zhang ZF; Wang YJ; Zheng YL; Lu J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):237. PubMed ID: 31171015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA DLX6-AS1 aggravates the development of ovarian cancer via modulating FHL2 by sponging miR-195-5p.
    Kong L; Zhang C
    Cancer Cell Int; 2020; 20():370. PubMed ID: 32774164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.